Does India's Ban on Electronic Cigarettes Improve Public Health Outcomes?

Apr.27.2023
Does India's Ban on Electronic Cigarettes Improve Public Health Outcomes?
The "Indian Public Policy Review" is a bi-monthly peer-reviewed journal covering various original papers, reviews, and comments on economic, political and strategic affairs, to promote research and advocacy development.

The Indian Public Policy Review is a bimonthly, peer-reviewed and open access journal. It covers original articles, book reviews, and commentaries in fields such as economics, political science, public finance, international relations and security, political and defense strategies, public enterprises, and technology policy. The journal's aim is to promote research and advocacy by providing articles on economic, political and strategic affairs. By launching the journal, it is hoped to encourage academic exchange on Indian public policy research. The journal publishes theory and empirical analysis papers related to Indian public policy issues, assisting scholars to timely publish their research findings, helping students understand and grasp the complexities of policy design and implementation, and giving policymakers insights to address the challenges brought by policy adjustments.


On March 31st, 2023, an article titled "Does India's Ban on Electronic Cigarettes Improve Public Health Outcomes?" was published in a journal by former Indian legislator Shonali Thangiah.


Image source: Front page of the paper "Will India's Ban on E-Cigarettes Improve Public Health Outcomes?" published in the April 2022 issue of the Indian Public Policy Review.


The summary of the paper is as follows:


1. Author Profile:


Mr. M. V. Rajeev Gowda, an Indian politician and scholar, is the author of this article. He served as a Member of Parliament in the lower house and national spokesperson for the Indian National Congress party from 2014 to 2020. He currently serves as the Chairperson of the Congress Research Department. At the Indian Institute of Management Bangalore, he was a professor of Economics and Social Sciences, as well as the Chairperson of the Center for Public Policy, and taught multiple courses. Additionally, he served as a Central Director of the Reserve Bank of India. Currently, he is an advisor to Bridge India, a progressive non-profit think tank based in London, which was established in 2018.


Image source: Homepage of the "M. V. Rajeev Gowda" Wikipedia article.


2. Background Overview:


In 2019, India passed the "Prohibition of Electronic Cigarettes Act," which banned a wide range of electronic nicotine delivery systems (ENDS), including e-cigarettes, vaping devices, and heated tobacco products (HNB). The government justified the ban based on certain risks, including their potential impact on health, their appeal to young people, and concerns that ENDS could undermine tobacco control efforts. This article applies a risk analysis framework to examine whether the ban will improve public health outcomes, or if regulation is a more effective alternative policy approach.


Part III: Discussion of Key Findings


The consequences and current state of the electronic cigarette ban.


Since the ban on e-cigarettes was introduced in 2019, there has been a significant rise in illegal online and offline black markets for electronic cigarettes, which goes against the initial intentions of policymakers. Consequently, many people are calling for more clear and scientific laws and regulations based on the harm reduction principle. Policy-making also needs to consider multiple factors, including economic benefits, tourism, crime rates, and adverse events related to public health. Finally, in the 2021 fiscal bill, the federal government accepted the new classification of tobacco and nicotine products developed by the World Customs Organization Committee, which recognizes the differences in taxation purposes between cigarettes, e-cigarettes, and heated non-combustible products. However, this distinction has not yet been applied in the context of the ban on e-cigarettes.


2. Tobacco Risk Management.


Smokeless tobacco is largely favored by specific demographics, including rural residents, those with lower levels of education and income, and marginalized communities. The dangers of smokeless tobacco are compounded by the unregulated product supply on the market.


In 2003, India instituted the comprehensive tobacco control law known as COTPA, which brought together various regulatory aspects under one framework. Another milestone in tobacco control was the National Tobacco Control Program (NTCP), which funds state-level tobacco control plans.


Risk balance serves as a criterion for evaluating policies.


The risk balance model allows the government to protect non-smokers and prevent overall tobacco use, while also protecting tobacco consumers by providing innovative low-risk products. By implementing bans and refusing to consider the possibility of using e-cigarettes as a tool to reduce tobacco-related harm, the government may also be depriving tobacco consumers of safer alternatives and their right to make informed decisions.


According to the FDA's "continuum of risk" theory, protecting high-risk tobacco products such as combustible cigarettes while banning low-risk products like ENDS and HNB could actually backfire and result in more tobacco-related deaths and illnesses. This would go against the government's basic responsibility to improve public health.


The global situation.


As of February 2021, 73 countries allow the sale of ENDS devices with restrictions (such as the UK, Canada, Malaysia, and New Zealand), while 37 countries have completely banned their sale (such as Australia, Singapore, Sri Lanka, and Thailand). Many countries have incorporated harm reduction principles into their tobacco control laws. New Zealand, the Philippines, Japan, Greece, and Switzerland have adopted risk proportionality and differential regulation for nicotine delivery systems and HNBs. Norway and Uruguay have lifted their ban on new tobacco products. The varied experiences and approaches taken by these countries provide an opportunity for research on how India can learn from them to regulate ENDS/HNB based on risk balance.


Lessons to be learned from the United States and the United Kingdom


The UK has taken a harm reduction approach, considering Electronic Nicotine Delivery Systems (ENDS) as a safer alternative to combustible tobacco. Regulation of tobacco and e-cigarettes falls under the Tobacco and Related Products Regulations 2016 (TRPR). Devices that do not contain nicotine are regulated under the General Product Safety Regulations 2005. TRPR aims to implement the European Union Tobacco Products Directive into UK law, discourage non-smokers, especially young people, from taking up smoking, and assist non-smokers in transitioning from smoking to cessation.


In contrast, the United States has adopted an abstinence approach, banning the use of ENDS in some jurisdictions. As the tobacco regulatory agency, the FDA classifies ENDS as ordinary cigarettes and requires ENDS manufacturers to apply for market approval for new and existing ENDS products in the United States. However, this authorization does not equate to FDA approval or official recognition of ENDS as safe products.


4. The implications for India:


The use of electronic cigarettes in India is limited to a specific demographic, consisting mainly of males with at least a Bachelor's degree and an average age of 29. This differs from those who smoke combustible cigarettes. Prior to the ban on e-cigarettes, only 0.02% of the population used them, compared to 10.7% who smoked traditional cigarettes.


Based on this fact, the author provides the following recommendations:


Initially allowed to heat without burning and regulated in accordance with existing tobacco product laws (i.e. COTPA), as they contained real tobacco. This initially limited the availability of e-cigarette products to HNB (rather than general ENDS), while still paving the way for harm reduction.


To further regulate the use of HNB, conditions such as geographic labeling, age restrictions, consumer purchase limits, and reducing harm information can be imposed under the "reasonable use" policy.


(3) Research on scientific evidence, international best practices, and commissioned studies on how to use HNB as a tool for harm reduction and smoking cessation, including statistical models and decision-making frameworks for comparing various interventions and their public health outcomes.


It will be considered a criminal offense to sell HNB (as well as traditional ENDS) directly or through intermediaries, in-person or online, to minors. Severe punishments will be imposed for any violations of this policy.


A strict regulatory framework should be put in place for HNB (and ENDS) products to prevent the health risks posed by unregulated products on the black market. Restrictions and standards for the devices, such as engineering, design, and materials, will ensure health and safety standards and prevent tampering and misuse through illegal additives.


If e-cigarettes were to be allowed under regulation, restrictions could include limiting the volume of e-liquid, the number of puffs, making refilling devices more cumbersome, and enforcing limitations on flavorings, additives, packaging and advertising. These measures would aim to reduce their appeal to young people and non-smokers.


Perform annual surveys on the utilization and trends of HNB and electronic cigarettes to ensure a proactive, adaptable, and evidence-based regulatory response.


Conclusion:


A policy based on abstinence has created a thriving black market in which the quality of products is unregulated, posing greater threats to public health through false and dangerous products. The government has also deprived itself of legitimate tax revenues. Therefore, the risks and opportunity costs of the ban outweigh the perceived benefits. A risk-balancing regulatory approach recognizes that the government can protect public health by constantly evaluating evidence and revising policies to address new risks. By prohibiting ENDS and HNB devices, the government has created a system that cannot readily respond to the unforeseen consequences it has set in motion. Eliminating this harm legislatively is both time and resource-intensive, and the damage to the health of those using illegal devices may even be irreversible.


Therefore, a evidence-based recommendation for India is to regulate heated tobacco products under the Cigarettes and Other Tobacco Products Act as they use tobacco. This can help reduce harm and promote innovation in the products, thus helping users break free from nicotine dependence and improving India's overall public health outcomes.


References:


Will India's Ban on E-Cigarettes Improve Public Health Outcomes?


Further reading:


According to recent scientific experiments, the flavors of nicotine and cannabis electronic cigarette products are the reasons why more teenagers are attracted to trying them out.


2. Science: Using self-control and perseverance to help quit smoking – an intervention strategy based on the theory of American psychologist Duckworth.


[Science] Latest scientific research reveals the connection between nicotine addiction and human identity cognition.


Latest research shows that the SGM (sexual and gender minority) community has a higher tobacco use rate compared to heterosexual individuals.


The latest release from the Macau Health Bureau's Smoking Prevention and Control Office is an exploration of "the current situation of electronic cigarette use among Macau youth and its influencing factors" in the field of science.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Global tobacco leaf markets diverged sharply in 2026, with India cutting authorised FCV production amid oversupply while Malawi faced a supply shortfall. U.S. demand improved in some leaf categories, but growers in Brazil, Colombia, Tanzania and Zimbabwe faced pressure from prices, buyer access, costs and weather. With nicotine consumption patterns also shifting, 2027 will test whether supply, demand and grower profitability can move back toward balance.
Oct.26
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23